Obtenga las últimas noticias sobre las acciones de Addex Therapeutics con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de ADXN

Últimas noticias sobre

Addex Therapeutics

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Section,Of,A,Financial,Newspaper,Titled,Key,Movers

News

Pre-Market Outlook

Markets

ADXN

BYND

CELC

CIIT

DCTH

DGXX

EXEL

FBGL

FCUV

FPAY

NCNA

OLMA

RANI

RAPT

TGHL

VIVK

XRTX

YGMZ

DCTH impulsa el premercado con resultados clínicos positivos del estudio CHOPIN, mientras Beyond Meat y Celcuity lideran las mayores subidas.

Acciones de Delcath Systems (DCTH) suben un 14%; Aquí están 20 acciones que se mueven en el premercado

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics Ltd

Press Releases

Addex Convenes Annual General Meeting 2025

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

Addex Shareholders Approve All Resolutions at Annual General Meeting

Addex Appoints Bank of New York Mellon as Depositary Bank

Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025

Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update

Addex Increases Issued Share Capital to Create Treasury Shares

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Artelo Biosciences

Athira Pharma

Biofrontera

Clearmind Medicine

Cocrystal Pharma

China Pharma Holding

Evoke Pharma

Gelteq

Impact BioMedical

IM Cannabis

Jaguar Health

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lipocine

Lyra Therapeutics

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

ProPhase Labs

Q/C Technologies

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

TherapeuticsMD

VYNE Therapeutics

cbdMD

HC Wainwright & Co.

Comments

Addex Therapeutics Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL